XML 22 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In- Capital
Treasury Stock
Accumulated Deficit
Noncontrolling Interest
Cumulative Effect Period Of Adoption Adjustment
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative effect change in accounting principle $ 1,018,413 $ 1,968 $ 4,151,147 $ (64,940) $ (3,069,272) $ (490) $ (55,885)
Balances at beginning of period at Dec. 31, 2018 1,018,413 1,968 4,151,147 (64,940) (3,069,272) (490) (55,885)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan   2 597        
Restricted stock, net   32 (32)        
Shares withheld for employee taxes   (4) (3,101)        
Other, net     48        
Compensation expense related to restricted stock grants     12,386        
Purchase of treasury stock       (14,157)      
Net income (loss) (98,661)       (98,065) (596)  
Noncontrolling interest contribution           6,566  
Cumulative effect change in accounting principle 866,204 1,998 4,161,045 (79,097) (3,223,222) 5,480 (55,885)
Balances at end of period at Jun. 30, 2019 866,204 $ 1,998 4,161,045 (79,097) (3,223,222) 5,480  
Balances at beginning of period (in shares) at Dec. 31, 2018   192,356,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan (in shares)   96,000          
Restricted stock grants, net (in shares)   3,320,000          
Shares withheld for employee taxes (in shares)   (450,000)          
Purchase of treasury stock (in shares)   (2,211,000)          
Balances at end of period (in shares) at Jun. 30, 2019   193,111,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative effect change in accounting principle 917,597 $ 2,000 4,154,790 (70,940) (3,167,752) (501) 0
Balances at beginning of period at Mar. 31, 2019 917,597 2,000 4,154,790 (70,940) (3,167,752) (501) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan   1 299        
Restricted stock, net   (3) 3        
Shares withheld for employee taxes   0 (108)        
Other, net     31        
Compensation expense related to restricted stock grants     6,030        
Purchase of treasury stock       (8,157)      
Net income (loss) (56,055)       (55,470) (585)  
Noncontrolling interest contribution           6,566  
Cumulative effect change in accounting principle 866,204 1,998 4,161,045 (79,097) (3,223,222) 5,480 0
Balances at end of period at Jun. 30, 2019 866,204 $ 1,998 4,161,045 (79,097) (3,223,222) 5,480  
Balances at beginning of period (in shares) at Mar. 31, 2019   194,573,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan (in shares)   46,000          
Restricted stock grants, net (in shares)   (214,000)          
Shares withheld for employee taxes (in shares)   (16,000)          
Purchase of treasury stock (in shares)   (1,278,000)          
Balances at end of period (in shares) at Jun. 30, 2019   193,111,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative effect change in accounting principle 866,204 $ 1,998 4,161,045 (79,097) (3,223,222) 5,480  
Cumulative effect change in accounting principle 698,725 1,996 4,172,099 (84,651) (3,393,088) 2,369 (115)
Balances at beginning of period at Dec. 31, 2019 698,725 1,996 4,172,099 (84,651) (3,393,088) 2,369 (115)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan   1 168        
Restricted stock, net   (7) 7        
Shares withheld for employee taxes   (6) (3,951)        
Other, net     37        
Compensation expense related to restricted stock grants     12,076        
Purchase of treasury stock       (18,123)      
Net income (loss) 251,077       251,114 (37)  
Noncontrolling interest contribution           0  
Cumulative effect change in accounting principle 939,889 1,984 4,180,436 (102,774) (3,142,089) 2,332 (115)
Balances at end of period at Jun. 30, 2020 $ 939,889 $ 1,984 4,180,436 (102,774) (3,142,089) 2,332  
Balances at beginning of period (in shares) at Dec. 31, 2019 192,128,586 192,129,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan (in shares)   61,000          
Restricted stock grants, net (in shares)   (579,000)          
Shares withheld for employee taxes (in shares)   (628,000)          
Purchase of treasury stock (in shares)   (3,063,000)          
Balances at end of period (in shares) at Jun. 30, 2020 187,919,675 187,920,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative effect change in accounting principle $ 1,052,230 $ 1,985 4,174,356 (102,774) (3,023,688) 2,351 0
Balances at beginning of period at Mar. 31, 2020 1,052,230 1,985 4,174,356 (102,774) (3,023,688) 2,351 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan   0 0        
Restricted stock, net   (1) 1        
Shares withheld for employee taxes   0 (59)        
Other, net     19        
Compensation expense related to restricted stock grants     6,119        
Purchase of treasury stock       0      
Net income (loss) (118,420)       (118,401) (19)  
Noncontrolling interest contribution           0  
Cumulative effect change in accounting principle 939,889 1,984 4,180,436 (102,774) (3,142,089) 2,332 $ 0
Balances at end of period at Jun. 30, 2020 $ 939,889 $ 1,984 4,180,436 (102,774) (3,142,089) 2,332  
Balances at beginning of period (in shares) at Mar. 31, 2020   188,012,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan (in shares)   0          
Restricted stock grants, net (in shares)   (75,000)          
Shares withheld for employee taxes (in shares)   (17,000)          
Purchase of treasury stock (in shares)   0          
Balances at end of period (in shares) at Jun. 30, 2020 187,919,675 187,920,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative effect change in accounting principle $ 939,889 $ 1,984 $ 4,180,436 $ (102,774) $ (3,142,089) $ 2,332